Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447135 · ClinicalTrials.gov registry record
Immunologic Function in the Elderly After Injury
A clinical trial, sponsored by Summa Health System.
- Completed
- Registry status
- 55
- Enrollment target
NCT00447135: Completed study, sponsored by Summa Health System.
NCT00447135 is a clinical trial that has completed, run by Summa Health System. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447135 has completed, sponsored by Summa Health System.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-12 |
What the finished NCT00447135 record still lists
NCT00447135 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00447135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00447135 about?
NCT00447135 is a clinical study titled "Immunologic Function in the Elderly After Injury". The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.
What is the current status of trial NCT00447135?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2005-03. Estimated completion is 2005-12.
Who is sponsoring clinical trial NCT00447135?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia